A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele.
about
Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study.Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect.The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment.A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin
P2860
Q36365500-A9C10053-7C53-40AA-9203-11F6CC5EF882Q38155218-D6027C06-2004-4CA0-8A6B-280AE2BD4A8DQ38417110-4755C6B6-9D09-481B-AF07-303934519E2CQ39032909-90E5B4C8-2809-4D30-8BE5-4AD55D03D115Q40081501-BDF9E2A4-D73C-48B0-9B22-02647EFFE578Q46702584-29609B6E-3C13-4188-9F00-F3A2EFCFB9B2Q48124606-BBFB7AAF-9856-4B07-8F5F-DEC1BC624065Q57749435-361E9D65-43C9-4F9D-B8DD-F97525667CEC
P2860
A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@en
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@nl
type
label
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@en
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@nl
prefLabel
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@en
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@nl
P2860
P356
P1433
P1476
A clinically significant inter ...... rriers of the CYP2C9*3 allele.
@en
P2093
Jonatan D Lindh
Marine L Andersson
P2860
P304
P356
10.2217/PGS.12.40
P577
2012-05-01T00:00:00Z